对宏观壮观症的医学疗法
Mônica R Gadelha1, Leandro Kasuki2, Carolina Aloan3
1Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Neuroendocrine Unit, Instituto Estadual do Cérebro Paulo Niemeyer, Secretaria Estadual de Saúde, Rio de Janeiro, Neuropathology and Molecular Genetics Laboratory, Secretaria Estadual de Saúde, R. Prof. Rodolpho Paulo Rocco, 255 - Cidade Universitária, Rio de Janeiro - RJ, 21941-617, Brazil.
手术是巨的主要治疗方法,但许多患者需要额外的医疗治疗. 目前的治疗方法并不总是有效,这促使人们对新药进行研究.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 巨症是一种罕见的激素疾病,由多余的生长激素引起.
- 手术是最初的治疗方法,但50%的患者需要进一步的医疗管理.
- 目前的疗法包括体静止素受体连接体,多巴胺激动剂和生长激素受体对手.
研究的目的:
- 审查目前对壮症的医疗管理.
- 讨论新兴的治疗策略和壮症治疗的未来方向.
主要方法:
- 对当前壮症治疗方法的文献综述.
- 对治疗疗效和患者结果的分析.
- 探索正在进行的研究和新药开发.
主要成果:
- 尽管有治疗方法,但许多壮症患者患有无法控制的疾病或持续的症状.
- 现有疗法在有效性和改善某些患者的生活质量方面存在局限性.
- 新的药物正在研究中,这些药物具有新的机制和注射途径.
结论:
- 目前用于壮症的医疗疗法对显著的患者小组来说是不够的.
- 进一步的研究是必不可少的,以开发更有效的治疗壮症.
- 未来的壮症管理可能需要新的药理学方法.
相关概念视频
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Skeletal Muscle Relaxants: Therapeutic Uses
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Cardiomyopathy V: Interprofessional Care
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...


